bas become aware of a spam email that fraudulently purports to have come from the address with the subject line "Investor Alert." The email contains potentially misleading financial information encouraging investment in a Chinese biotechnology company.

THIS EMAIL IS A HOAX. is notifying you of this fraud so that you may discard all information purporting to originate from

Please be advised that did not participate in any way in creating or disseminating this email, nor has provided the unknown perpetrators with any personal information about its subscribers. takes seriously its obligation to protect its subscribers and only disseminates information to third parties in accordance with its published privacy policy and applicable law.

To further protect its customers, has undertaken a full investigation of this matter. To assist us in this regard, we would be grateful if you or your technology department could forward any SMTP address information regarding the above email to .

In the future, if you suspect that you have received a fraudulent email purporting to originate from, please forward it to us at without changing or retyping the subject line. You may also call our Customer Service department at 1-866-321-8726, Monday-Friday, 8 a.m. to 6 p.m. ET. In addition, you may wish to notify the Federal Trade Commission at .

Thanks, and we apologize for any inconvenience.

Dave Morrow

David Morrow is editor-in-chief of In keeping with TSC's editorial policy, he doesn't own or short individual stocks, though he owns stock in He also doesn't invest in hedge funds or other private investment partnerships. He appreciates your feedback; click here to send him an email.